Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 8 de 8
1.
Autism ; 28(1): 187-198, 2024 Jan.
Article En | MEDLINE | ID: mdl-36999343

LAY ABSTRACT: It is vital to directly engage with the autism community in order to develop better services and drive the research agenda. While some studies in high-income countries have mapped the priorities of the autism community, there is a severe dearth of such efforts in the global south. Five million autistic individuals are estimated to live in India alone, and there has been little effort to map their priorities. Moreover, studies in high-income countries focused largely on research priorities, and not so much on skills training and interventions. Keeping these needs in mind, we conducted an online survey followed by an in-depth conversation with parents of autistic children and autistic adults drawn from across India. We found that the respondents reported self-help skills to be the most important for training, as they considered it fundamental for every other aspect of life. Speech and language therapy was considered to be the highest intervention priority for this group, highlighting the importance of social communication. Mental health counselling was also considered to be a high priority, but several parents identified it as being more relevant for themselves rather than for their children. Within research, the topmost priority was to understand ways in which the community can better support autistic people. We hope that these findings will help researchers, policymakers and service providers to be able to make well-informed decisions, develop relevant services and shape future research.


Autism Spectrum Disorder , Autistic Disorder , Adult , Child , Humans , Autistic Disorder/therapy , Autism Spectrum Disorder/therapy , Exercise , Speech Therapy , India
2.
Cell Host Microbe ; 31(10): 1700-1713.e4, 2023 10 11.
Article En | MEDLINE | ID: mdl-37725983

Fungal infections are a global threat; yet, there are no licensed vaccines to any fungal pathogens. Th17 cells mediate immunity to Candida albicans, particularly oropharyngeal candidiasis (OPC), but essential downstream mechanisms remain unclear. In the murine model of OPC, IκBζ (Nfkbiz, a non-canonical NF-κB transcription factor) was upregulated in an interleukin (IL)-17-dependent manner and was essential to prevent candidiasis. Deletion of Nfkbiz rendered mice highly susceptible to OPC. IκBζ was dispensable in hematopoietic cells and acted partially in the suprabasal oral epithelium to control OPC. One prominent IκBζ-dependent gene target was ß-defensin 3 (BD3) (Defb3), an essential antimicrobial peptide. Human oral epithelial cells required IκBζ for IL-17-mediated induction of BD2 (DEFB4A, human ortholog of mouse Defb3) through binding to the DEFB4A promoter. Unexpectedly, IκBζ regulated the transcription factor Egr3, which was essential for C. albicans induction of BD2/DEFB4A. Accordingly, IκBζ and Egr3 comprise an antifungal signaling hub mediating mucosal defense against oral candidiasis.


Candidiasis, Oral , Candidiasis , Humans , Mice , Animals , Candidiasis, Oral/genetics , Candidiasis, Oral/microbiology , Candida albicans , Mucous Membrane , Transcription Factors/genetics , Adaptor Proteins, Signal Transducing
3.
J Immunol ; 211(2): 252-260, 2023 07 15.
Article En | MEDLINE | ID: mdl-37265402

SARS-CoV-2 has caused an estimated 7 million deaths worldwide to date. A secreted SARS-CoV-2 accessory protein, known as open reading frame 8 (ORF8), elicits inflammatory pulmonary cytokine responses and is associated with disease severity in COVID-19 patients. Recent reports proposed that ORF8 mediates downstream signals in macrophages and monocytes through the IL-17 receptor complex (IL-17RA, IL-17RC). However, generally IL-17 signals are found to be restricted to the nonhematopoietic compartment, thought to be due to rate-limiting expression of IL-17RC. Accordingly, we revisited the capacity of IL-17 and ORF8 to induce cytokine gene expression in mouse and human macrophages and monocytes. In SARS-CoV-2-infected human and mouse lungs, IL17RC mRNA was undetectable in monocyte/macrophage populations. In cultured mouse and human monocytes and macrophages, ORF8 but not IL-17 led to elevated expression of target cytokines. ORF8-induced signaling was fully preserved in the presence of anti-IL-17RA/RC neutralizing Abs and in Il17ra-/- cells. ORF8 signaling was also operative in Il1r1-/- bone marrow-derived macrophages. However, the TLR/IL-1R family adaptor MyD88, which is dispensable for IL-17R signaling, was required for ORF8 activity yet MyD88 is not required for IL-17 signaling. Thus, we conclude that ORF8 transduces inflammatory signaling in monocytes and macrophages via MyD88 independently of the IL-17R.


COVID-19 , Open Reading Frames , SARS-CoV-2 , Animals , Humans , Mice , COVID-19/immunology , COVID-19/virology , Cytokines/metabolism , Macrophages/metabolism , Monocytes/metabolism , Myeloid Differentiation Factor 88/genetics , Myeloid Differentiation Factor 88/metabolism , Receptors, Interleukin-17/genetics , Receptors, Interleukin-17/metabolism , SARS-CoV-2/metabolism
4.
Exp Mol Pathol ; 116: 104485, 2020 10.
Article En | MEDLINE | ID: mdl-32574668

Septic arthritis is a condition of bone disorder caused predominantly by Staphylococcus aureus. Following the bacterial entry activated immune cells specially macrophages and dendritic cells release pro-inflammatory mediators such as IL-6, TNF-α, IL-1ß etc., which not only create an inflammatory microenvironment but also play crucial roles in the proliferation of different CD+ T cell subsets. Among them, Th17 and Tregs are of major concern in recent times because of their potential roles in regulating the ongoing inflammation in many diseases including experimental arthritis. But the downstream signalling mechanism of these cells in regulating the severity of inflammation in case of septic arthritis is not known yet. So, here we have established a murine model of S. aureus induced septic arthritis and kept the animal upto 15 days post-infection. To examine the signalling mechanism, Th17 and Treg cells were isolated from blood, spleen and synovial joints of control and infected mice and observed the expression of JNK, NFκB and RANKL in the lysate of isolated Th17 and Tregs. We have also estimated the levels of serum IL-21 and TGF-ß. NFκB, JNK and RANKL expression was found to be higher at 3 and 15 days post-infection along with serum IL-21 levels. On the other hand, maximum TGF-ß level was observed at 9 days post-infection along with increased Treg population. In conclusion it was hypothesized that bone resorption is related with downstream signalling pathways of Th17 cells, which stimulate osteoclast generation via NFκB/JNK-RANKL axis and helps in the persistence of the disease.


Arthritis, Infectious/immunology , Inflammation/immunology , Staphylococcal Infections/immunology , T-Lymphocytes, Regulatory/immunology , Th17 Cells/immunology , Animals , Arthritis, Experimental/genetics , Arthritis, Experimental/immunology , Arthritis, Experimental/microbiology , Arthritis, Experimental/pathology , Arthritis, Infectious/genetics , Arthritis, Infectious/microbiology , Arthritis, Infectious/pathology , Gene Expression Regulation/genetics , Humans , Inflammation/genetics , Inflammation/microbiology , Inflammation/pathology , Interleukin-1beta/genetics , Joints/immunology , Joints/microbiology , Joints/pathology , MAP Kinase Kinase 4/genetics , Mice , Osteoclasts/immunology , Osteoclasts/microbiology , Osteoclasts/pathology , RANK Ligand/genetics , Signal Transduction/genetics , Staphylococcal Infections/genetics , Staphylococcal Infections/microbiology , Staphylococcal Infections/pathology , Staphylococcus aureus/pathogenicity , T-Lymphocytes, Regulatory/microbiology , Th17 Cells/microbiology , Transforming Growth Factor beta/genetics , Tumor Necrosis Factor-alpha/genetics
6.
Microb Pathog ; 139: 103903, 2020 Feb.
Article En | MEDLINE | ID: mdl-31790794

The contribution of Th17 and Treg in the pathogenesis of septic arthritis is well known. The imbalance of Th17/Treg ratio, especially the skewed CD4+ T cell differentiation towards pathogenic Th17 lineage is a major reason that mediates bone damage through one of its prime cytokine member IL-17A. The neutralization of released IL-17A, as well as exogenous administration of IL-2 at a lower dose, was seen to be potent in dampening the inflammatory response in many cases. Interestingly the effect of IL-17A neutralization to limit IL-17 mediated inflammation and induction of Tregs by the administration of IL-2 has not been studied in experimental arthritis. So in this study, we have treated arthritic mice with IL-17A Ab and recombinant mouse IL-2 either alone or in combination at 3, 9 and 15 days post-infection. We have found a marked decrease in Th17 cell population and their related pro-inflammatory cytokine levels at 15DPI in arthritic mice after IL-17 neutralization. An increased Treg cell population was also observed in mice after application of rIL-2 with a significantly heightened TGF-ß level in serum and synovial joints compared to the untreated one. However, in the case of combination therapy of IL-17A Ab and rIL-2 we have observed a beneficial effect in ameliorating the disease outcome as the arthritic index was decreased maximally at 15DPI with a significant reduction of arthritis compared to individual treatment. Overall the inflammatory microenvironment was counterbalanced most effectively in combination treatment by lowering the Th17/Treg ratio and their related cytokines that resulted in reducing the immunopathogenesis of the destructive arthritis.


Antibodies/administration & dosage , Arthritis, Infectious/drug therapy , Interleukin-17/immunology , Interleukin-2/administration & dosage , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Th17 Cells/drug effects , Animals , Arthritis, Infectious/immunology , Arthritis, Infectious/microbiology , Cell Differentiation , Humans , Male , Mice , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Staphylococcus aureus/physiology , Th17 Cells/cytology , Th17 Cells/immunology , Transforming Growth Factor beta/immunology
7.
Microb Pathog ; 113: 248-264, 2017 Dec.
Article En | MEDLINE | ID: mdl-29074430

Intravenous inoculation of Swiss mice with S. aureus leads to severe synovial joint tissue swelling along with prominent T lymphocyte infiltrate with associated inflammation in synovial tissue. Cytokines released from macrophages such as TNF-α, IL-1ß and IL-6 the main players that precede cartilage and bone destruction during septic arthritis (SA) followed by osteoclast differentiation and bone resorption. CD4+ naïve T cells upon cytokine driven activation, differentiate into lineages of helper (Th) and regulatory T cells (Treg) including inflammatory Th17 cell lineage. Acting as counterbalance, Tregs protect the host by releasing anti-inflammatory IL-10. A disturbed balance between Th17 and Treg cell development skews the pathways towards Th17 lineage, but how it actually induces SA is still unexplored. Therefore, this study has been attempted to demonstrate the Th17/Treg ratio in synovial tissue, spleen and peripheral blood by FACS and their derived cytokines from serum of arthritic mice. Here, we reported that the ratios of Th17/Treg as well as their related cytokine levels were increased at 3 days post-infection which was decreased during 9 DPI but heightened again at 15DPI resulting in persistence of the disease, though decreased again at 30 DPI even in animals with increased dose of infection. Bacterial colonies were present in synovial joints at 15 DPI in animals with increased infection but found to be absent at 30 DPI. Maintaining Th17/Treg balance by neutralizing functionally active Th17 and their related cytokines or adoptive transfer of fully active Tregs and/or their related cytokines may lead to a novel therapeutic strategy for combating Staphylococcal arthritis.


Arthritis, Infectious/immunology , Arthritis, Infectious/microbiology , Cytokines/metabolism , Staphylococcus aureus/pathogenicity , T-Lymphocytes, Regulatory/physiology , Th17 Cells/physiology , Animals , Arthritis, Infectious/blood , Arthritis, Infectious/physiopathology , Bone Resorption , CD4-Positive T-Lymphocytes , Cell Differentiation , Colony Count, Microbial , Disease Models, Animal , Inflammation , Interleukin-10/metabolism , Interleukin-17/metabolism , Interleukin-23/metabolism , Lymphocytes , Macrophages/immunology , Macrophages/microbiology , Male , Mice , Osteoclasts , Spleen/microbiology , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Synovial Membrane/microbiology , Tumor Necrosis Factor-alpha/metabolism
8.
Inflammation ; 38(3): 1050-69, 2015.
Article En | MEDLINE | ID: mdl-25429758

We hypothesized that if internalization of Staphylococcus aureus could be blocked by using cytochalasin D (an inhibitor of phagocytosis and phagolysosome fusion), then the intracellular entry and survival of the pathogen in host's phagocytic cells recruited to the inflammatory site can be restricted. At the same time, if we use antimicrobial agents (e.g., ciprofloxacin and azithromycin) having potent intracellular and extracellular microbicidal activity against the bacterium that have not entered into the phagosome and remains adhered to the phagocytic cell membrane, then they can be eradicated from the site of infection without compromising the host cell. To validate this, role of ciprofloxacin (CIP) and azithromycin (AZM) in eliminating S. aureus by suppressing the phagocytic activity of macrophages with cytochalasin D before infection was investigated. CIP and AZM were used either alone or in combination with cytochalasin D. Supernatant and lysate obtained from the culture of macrophages were used for quantification of reactive oxygen species, lysozymes, antioxidant enzymes, and cytokines produced. Azithromycin was better than ciprofloxacin in combination with cytochalasin D for eradicating S. aureus and regulating cytokine release. Further studies are required for ensuring proper delivery of this combination at the site of infection.


Azithromycin/therapeutic use , Ciprofloxacin/therapeutic use , Cytochalasin D/therapeutic use , Macrophages/immunology , Staphylococcal Infections/drug therapy , Animals , Anti-Bacterial Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antioxidants/metabolism , Drug Therapy, Combination , Glutathione/metabolism , Hydrogen Peroxide/metabolism , Inflammation/drug therapy , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-6/metabolism , Male , Mice , Microbial Sensitivity Tests , Muramidase/metabolism , Phagocytosis/immunology , Staphylococcal Infections/immunology , Staphylococcal Infections/microbiology , Staphylococcus aureus/immunology , Staphylococcus aureus/isolation & purification , Staphylococcus aureus/pathogenicity , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism
...